Mudgaparni: Benefits, Evidence & Safety

TL;DR

Mudgaparni (Vigna trilobata / Phaseolus trilobus) is an Ayurvedic rejuvenative herb used traditionally for debility, fever, and liver complaints. Rat studies show its extracts lowered elevated liver enzymes and protected against paracetamol- and bile-duct-ligation-induced liver injury, but no human trials exist. (41 words. Sources: Fursule & Patil 2010, J. Ethnopharmacol; Patil & Fursule 2008; IJAMRED 2026 review.)

What it is

Mudgaparni is Vigna trilobata (L.) Verdc., synonym Phaseolus trilobus Ait., a leguminous plant of the family Fabaceae (IJAMRED review). In Ayurveda the root and the whole plant are the parts used. Charaka places Mudgaparni among the Jivaniya (vitality-promoting) and Shukrajanana groups of herbs (List of herbs in Charak Samhita).

Traditional use

Classical Ayurvedic literature describes Mudgaparni as balya (strengthening), brimhana (nourishing), rasayana (rejuvenative) and tridoshashamaka, and it has been used in the management of general debility, fever, respiratory disorders, inflammatory conditions and nutritional deficiencies (IJAMRED review). In the Nandurbar district of Maharashtra, tribal communities use Phaseolus trilobus for jaundice and other liver disorders (Fursule & Patil 2010, PubMed). These are traditional and ethnomedical uses, not clinical proof.

What modern research says

Hepatoprotective activity (animal study)

In bile-duct-ligated Wistar rats, methanol and aqueous extracts of Phaseolus trilobus significantly (p<0.01) reduced elevated ALT, AST, ALP, LDH, bilirubin and hydroxyproline, with effects comparable to the reference drug silymarin (Fursule & Patil 2010, J. Ethnopharmacol).

Protection against paracetamol-induced liver damage (animal study)

Methanol extract of P. trilobus seeds at 125, 250 and 500 mg/kg reversed paracetamol-induced elevation of liver marker enzymes, restored glutathione and Na⁺-K⁺ ATPase, and limited histological liver damage in rats: comparable to silymarin (Patil & Fursule 2008, J. Pharmacol. Toxicol.).

Antioxidant activity (in-vitro study)

Protein extract isolated from V. trilobata showed 87.88% DPPH radical inhibition at 10 mg/ml and significant ABTS scavenging and ferric-reducing power, indicating antioxidant activity in test-tube assays (IJAMRED review).

Antidiabetic activity (animal study, preliminary)

Oral administration of Phaseolus trilobus root extract (400 mg/kg) significantly decreased blood glucose on days 15 and 20 in diabetic rats, comparable to glibenclamide: a single animal study, far from human evidence (IJAMRED review).

Sedative activity (animal study, preliminary)

Aqueous leaf extract at 200 and 400 mg/kg reduced locomotor activity and rotarod fall-off time in mice in a dose-dependent manner, compared against diazepam: an isolated animal finding with no human follow-up (IJAMRED review).

Evidence is entirely preclinical; the 2026 IJAMRED review itself concludes that standardization, toxicity profiling and human clinical trials are still lacking (IJAMRED review).

Safety & contraindications

Safety data is limited: talk to a clinician. No published human safety studies, pregnancy or lactation data, or drug-interaction data for Mudgaparni were located; existing studies are short-term animal experiments, not safety trials. Do not use Mudgaparni medicinally during pregnancy or breastfeeding, or alongside liver-affecting medication, without qualified supervision.

FAQs

What is Mudgaparni?

Mudgaparni is Vigna trilobata (syn. Phaseolus trilobus), a wild leguminous plant of the Fabaceae family. In Ayurveda, its root and whole plant are classed among strength-promoting (balya) and rejuvenative (rasayana) herbs (IJAMRED review).

Is there any human evidence for Mudgaparni?

No human trials were found. All published pharmacological evidence, including the liver-protective and antioxidant findings, comes from animal or test-tube studies. A 2026 peer-reviewed review explicitly states that human clinical validation is still needed (IJAMRED review).

Is Mudgaparni the same as green gram (mudga)?

No. Green gram (mudga) is Vigna radiata, a cultivated pulse eaten as food. Mudgaparni is Vigna trilobata (syn. Phaseolus trilobus), a distinct wild legume used medicinally: the similar names cause frequent confusion.

Is Mudgaparni safe?

Safety data is limited. No human safety, pregnancy, lactation, or interaction data exist; animal studies are efficacy experiments, not safety trials. Consult a qualified practitioner or clinician before any medicinal use (IJAMRED review).

What did the liver studies actually show?

In rats, Mudgaparni extracts lowered elevated liver enzymes and improved liver histology in two models of liver injury, paracetamol toxicity and bile-duct ligation, with effects comparable to silymarin. These are animal findings and do not mean it treats human liver disease (PubMed 20430092; Patil & Fursule 2008).

Sources

Tier 1 — peer-reviewed journals and reviews:

Tier 3 — Ayurvedic herb references:

This article is for educational purposes only and is not medical advice. Consult a qualified Ayurvedic practitioner or clinician before using Mudgaparni medicinally.